| Analysis | Metabolite Name | Measured Value | Units | Genotype | Treatment | Metabolite | Tissue |
|---|---|---|---|---|---|---|---|
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.071 | ng/mL | F344 Pirc | AIN-93G (control) | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.143 | ng/mL | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.146 | ng/mL | F344 Pirc | EPA-FFA (2% EPA) | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.147 | ng/mL | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.149 | ng/mL | F344 Pirc | 200 ppm Naproxen | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.164 | ng/mL | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.164 | ng/mL | F344 Pirc | LD TP-252 (1.5% EPA) | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.165 | ng/mL | F344 Pirc | 200 ppm Naproxen | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.182 | ng/mL | F344 Pirc | HD TP-252 (3% EPA) | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.199 | ng/mL | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.208 | ng/mL | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.223 | ng/mL | F344 Pirc | HD TP-252 (3% EPA) | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.225 | ng/mL | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.242 | ng/mL | F344 Pirc | LD TP-252 (1.5% EPA) | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.248 | ng/mL | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.254 | ng/mL | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.259 | ng/mL | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.276 | ng/mL | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.282 | ng/mL | F344 Pirc | HD TP-252 (3% EPA) | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.298 | ng/mL | F344 Pirc | HD TP-252 (3% EPA) | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.346 | ng/mL | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 0.409 | ng/mL | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Eicosanoid | Plasma |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 2.063 | ng/g tissue | F344 Pirc | AIN-93G (control) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 2.514 | ng/g tissue | F344 Pirc | EPA-FFA (2% EPA) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 2.536 | ng/g tissue | F344 Pirc | EPA-FFA (2% EPA) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 2.791 | ng/g tissue | F344 Pirc | EPA-FFA (2% EPA) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 2.883 | ng/g tissue | F344 Pirc | EPA-FFA (2% EPA) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 3.510 | ng/g tissue | F344 Pirc | HD TP-252 (3% EPA) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 3.892 | ng/g tissue | F344 Pirc | 200 ppm Naproxen | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 3.990 | ng/g tissue | F344 Pirc | HD TP-252 (3% EPA) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 4.224 | ng/g tissue | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 4.433 | ng/g tissue | F344 Pirc | HD TP-252 (3% EPA) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 4.661 | ng/g tissue | F344 Pirc | EPA-FFA (2% EPA) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 6.076 | ng/g tissue | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 6.179 | ng/g tissue | F344 Pirc | AIN-93G (control) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 7.288 | ng/g tissue | F344 Pirc | HD TP-252 (3% EPA) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 8.264 | ng/g tissue | F344 Pirc | HD TP-252 (3% EPA) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 8.534 | ng/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 8.676 | ng/g tissue | F344 Pirc | HD TP-252 (3% EPA) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 10.466 | ng/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 11.758 | ng/g tissue | F344 Pirc | AIN-93G (control) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 13.773 | ng/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 13.931 | ng/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 14.094 | ng/g tissue | F344 Pirc | EPA-FFA (2% EPA) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 14.939 | ng/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 17.368 | ng/g tissue | F344 Pirc | AIN-93G (control) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 17.550 | ng/g tissue | F344 Pirc | AIN-93G (control) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 19.607 | ng/g tissue | F344 Pirc | HD TP-252 (3% EPA) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 20.896 | ng/g tissue | F344 Pirc | AIN-93G (control) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 21.625 | ng/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | 29.077 | ng/g tissue | F344 Pirc | AIN-93G (control) | Eicosanoid | Tumor-adjacent normal colon |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | ng/g tissue | F344 Pirc | 200 ppm Naproxen | Eicosanoid | Tumor-adjacent normal colon | |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | ng/g tissue | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Eicosanoid | Tumor-adjacent normal colon | |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | ng/g tissue | F344 Pirc | EPA-FFA (2% EPA) | Eicosanoid | Tumor-adjacent normal colon | |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | ng/g tissue | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Eicosanoid | Tumor-adjacent normal colon | |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | ng/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Eicosanoid | Tumor-adjacent normal colon | |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | ng/g tissue | F344 Pirc | LD TP-252 (1.5% EPA) | Eicosanoid | Tumor-adjacent normal colon | |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | ng/mL | F344 Pirc | 200 ppm Naproxen | Eicosanoid | Plasma | |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | ng/mL | F344 Pirc | AIN-93G (control) | Eicosanoid | Plasma | |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | ng/mL | F344 Pirc | EPA-FFA (2%) + 200 ppm Naproxen | Eicosanoid | Plasma | |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | ng/mL | F344 Pirc | EPA-FFA (2% EPA) | Eicosanoid | Plasma | |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | ng/mL | F344 Pirc | HD TP-252 (3% EPA) + 200 ppm Naproxen | Eicosanoid | Plasma | |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | ng/mL | F344 Pirc | HD TP-252 (3% EPA) | Eicosanoid | Plasma | |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | ng/mL | F344 Pirc | LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Eicosanoid | Plasma | |
| None (Direct infusion) NEGATIVE ION MODE | Bicyclo PGE1 | ng/mL | F344 Pirc | LD TP-252 (1.5% EPA) | Eicosanoid | Plasma |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|